A carregar...

Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Metab Brain Dis
Main Authors: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://ncbi.nlm.nih.gov/pubmed/27525431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!